StocksMedium6 August 2026
1 min read

Mixed Q2 Results for Energy and Biotech as Sempra and TC Energy Beat Estimates

Key Facts

1Sempra topped Q2 earnings estimates despite revenues dipping and missing forecasts.
2TC Energy beat Q2 earnings and revenue estimates, raising its full-year EBITDA guidance.
3Recursion missed Q2 earnings and revenue estimates, leading to a decline in its share price.

Amidst an earnings season reflecting divergent operational performance across vital sectors, three major companies reported their Q2 2026 financial results. According to reports, Sempra managed to top earnings estimates despite revenues dipping below forecasts, driven by a surge in utility profits. Conversely, TC Energy demonstrated strong performance by beating both earnings and revenue estimates, leading the company to raise its full-year EBITDA guidance, while Recursion posted a miss on both lines due to falling collaboration revenues.

Looking at energy sector performance per market data, SRE shares closed at $84.66 on August 5, 2026, after reaching a daily high of $86.82. In the same context, TC Energy showed operational resilience reflected in its TRP share price, which closed at $63.86 on the same date, amid a broader trend of large-cap firms balancing profit growth against revenue volatility in a shifting economic environment.

Traders should watch support levels for SRE near its recent low of $84.11 and for TRP at $63.72 (as of August 5, 2026 close). With no immediate catalysts in the upcoming economic calendar specifically for these instruments, focus remains on the sustainability of Sempra's utility profit growth and TC Energy's ability to meet its updated annual EBITDA targets.

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.